This federal contract award is for the delivery of BOTOX 200 unit vials to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The fixed-price delivery order, valued at $3,011.25, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a period of performance through December 11, 2024.
Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.
The contract award does not indicate the use of any set-aside requirements, suggesting open competition. As a major supplier of pharmaceutical and medical products to federal agencies, Amerisourcebergen's extensive experience and capabilities make it well-positioned to support the DLA's medical supply needs for military healthcare programs.
Generated 2/18/25, 1:39 PM